tumor mutational burden

Data presented at the meeting underscored the importance of studying diverse populations in order to improve equity in precision oncology.

Adding Moderna's vaccine to Merck's checkpoint inhibitor in the adjuvant treatment setting benefited melanoma patients, even across biomarker groups like TMB and PD-L1.

The firm is growing its sales, product marketing, and customer service teams for its multiomic metastatic breast cancer liquid biopsy test, DefineMBC.